Health Risks of Smoking
Smoking is the single most significant preventable cause of disease and premature death, responsible for approximately 440,000 deaths annually in the United States, with 30% of all cancer deaths and 20% of cardiovascular deaths directly attributable to tobacco use. 1, 2
Cancer Risks
Smoking demonstrates convincing causal evidence for multiple malignancies with dose-response relationships:
High-Risk Cancers (Relative Risk ≥2.0)
- Lung cancer: 80-90% of cases are smoking-attributable, with 85-90% of lung cancer deaths caused by cigarettes 3, 2
- Oral cavity, pharyngeal, and laryngeal cancers
- Esophageal cancer (both squamous cell and adenocarcinoma)
- Bladder and kidney cancers
- Pancreatic cancer 1, 2
Moderate-Risk Cancers (Relative Risk 1.35-1.99)
Probable Links
- Prostate cancer (paradoxically decreased risk)
- Liver cancer 1
The risk follows a clear dose-response relationship with number of cigarettes smoked daily, depth of inhalation, and duration of smoking (pack-years) 3.
Cardiovascular Disease Risks
Smoking approximately doubles the 10-year fatal cardiovascular risk and is responsible for nearly 20% of all cardiovascular deaths 5.
Specific Cardiovascular Conditions
- Acute myocardial infarction: RR 2.45 (95% CI 2.22-2.70) 6
- Cerebrovascular disease/stroke: RR 2.16 (95% CI 1.93-2.42) 6
- Heart failure: RR 2.23 (95% CI 1.96-2.53) 6
- Peripheral arterial disease: RR 5.06 (95% CI 4.47-5.74) - the highest cardiovascular risk 6
- Atrial fibrillation/flutter: RR 1.31 (95% CI 1.20-1.44) 6
- Pulmonary embolism: RR 1.41 (95% CI 1.17-1.70) 6
Critical age-related finding: The relative risk of myocardial infarction in smokers under 50 years is five-fold higher than non-smokers, compared to only doubled risk in older smokers 5.
Respiratory Disease Risks
Chronic Respiratory Conditions
- COPD: RR 4.01 (95% CI 3.18-5.05) - over 80% of cases attributable to smoking 7, 8
- Obstructive chronic bronchitis: Strong causal evidence 7
- Emphysema: RR 1.63 (95% CI 0.90-2.36) 7
- Asthma: RR 1.61 (95% CI 1.07-2.42) in adults; increased risk and exacerbations 7, 8
- Chronic airway obstruction: RR 0.83 (95% CI 0.30-1.36) 7
- Pneumococcal pneumonia: RR 0.30 (95% CI 0.11-0.49) 7
- Tuberculosis: Increased risk for both active disease and reactivation 4
Metabolic and Endocrine Risks
Type 2 diabetes: Smoking is an independent and modifiable risk factor 2, 7, 4
- Heavy smokers (≥2 packs/day): 45-74% higher incidence than never-smokers
- Dose-dependent relationship: ≥15 cigarettes/day confers 30-40% higher risk
- Important caveat: Quitting reduces diabetes risk to baseline after 5-10 years, despite potential weight gain 2
Other Metabolic Conditions
- Polycystic ovary syndrome 4
Musculoskeletal and Other Systemic Risks
- Fractures and osteoporosis 4
- Osteoarthritis 4
- Rheumatoid arthritis 4
- Diverticular disease 4
- Gallstone disease 4
- Gastroesophageal reflux disease 4
- Crohn's disease 4
- Acute pancreatitis 4
- Periodontitis 4
- Epilepsy 4
- Age-related macular degeneration 4
- Senile cataract 4
- Sleep apnea 3
Gender-Specific Risks
Women face disproportionately higher risks than men at equivalent smoking levels 9:
- Low-level smoking (1-20 cigarettes/day): RR 1.77 for women vs. 1.42 for men
- High-level smoking (>20 cigarettes/day): RR 2.75 for women vs. 1.95 for men
- Women metabolize nicotine faster, especially those on oral contraceptives, potentially leading to compensatory smoking 5
Secondhand Smoke Risks
Passive smoking increases disease risk substantially 3, 2:
- Lung cancer: 20-30% increased risk for non-smokers living with smokers; RR 1.24 overall 3
- Cardiovascular disease: 30% higher risk for non-smoking spouses of smokers 5
- Responsible for 38,000-64,000 deaths annually in non-smokers 2, 10
- Over 64% of secondhand smoke deaths occur in women 10
Children's Risks from Passive Smoke
- Increased asthma incidence and exacerbations
- Lower respiratory infections
- Reduced lung function
- Sudden infant death syndrome 3, 8
Pregnancy-Related Risks
- Ectopic pregnancy
- Orofacial clefts in infants
- Fetal growth restriction
- Preterm delivery (5.3-7.7% attributable)
- Low birthweight (13.1-19.0% attributable)
- Sudden infant death syndrome (23.2-33.6% attributable)
- Preterm-related deaths (5.0-7.3% attributable) 11
Dose-Response Relationship
There is no safe level of smoking 5. Risk increases with:
- Number of cigarettes per day
- Depth of inhalation
- Duration of smoking (pack-years)
- Age of initiation (earlier start = higher lifetime risk)
Even light smoking (4-6 cigarettes/day) significantly increases mortality risk: RR 1.92 for total CVD mortality 6.
Economic Impact
The economic burden is staggering 1, 2:
- $75 billion in annual medical expenses
- $81 billion in lost productivity from premature death
- $157.7 billion total health-related economic losses annually (1995-1999 data)
Critical Clinical Implications
Smoking harms nearly every organ system in the body 3. The evidence is unequivocal that:
No tobacco product is safe: This includes low-tar cigarettes, cigars, pipes, waterpipes, smokeless tobacco, heated tobacco products, and e-cigarettes 2, 12
Persistent smoking in cancer patients worsens outcomes: Associated with second primary cancers, treatment complications, and decreased survival 3
Quitting substantially reduces risk: After myocardial infarction, smoking cessation shows mortality benefit of 0.64 (95% CI 0.58-0.71) compared to continued smokers, with benefits evident within 6 months 5
No age limit to benefits: Even quitting in the 50s and 60s significantly reduces cancer and cardiovascular risk 1
Excess risks largely avoided by quitting before age 45 6